Pfizer Inc.PFE
Buy moreBuy more on a dip to our buy price, which is under Friday's $27.
- 4 good· Earnings beat
- 3 to watch· Below 50-day
$27.43−0.11 (−0.40%)
After hours $27.44 +0.2% · 7:52 PM ET on Friday
Price at 3:59 PM ET on Friday
Market closed · opens in 22h 24mNext open: Monday, Nov 23, 9:30 AM ETNYSE · Healthcare · Drug Manufacturers - General · Large company
The price we'd buy PFE at comes with a free account
It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.
What would change it
Sources
- Yahoo Finance daily closes to Nov 20
Could move it to Keep
Compared with the S&P 500
6 points
worse in one day
13 points
worse in five trading days
+19.9% in a yearsince Nov 20, 2025
The news behind our call
On Nov 20, Pfizer was described as pursuing growth through blockbuster medicines, an expanding pipeline, and strategic investment.
What changed
Overview
Key figures
- Revenue (TTM)
- $63.6B
- Revenue growth, 1 year
- +1.3%
- Net income
- $4.0B
- EPS (diluted)
- $0.70
- Gross margin
- 74.9%
- Operating margin
- 29.1%
- Return on equity
- 4.5%
- Return on capital
- 12.8%
- Debt / equity
- 0.71
- Current ratio
- 1.42
- Dividend yield
- 6.27%
- Buyback yield
- -0.46%
Key facts
- Company value
- $156B
- Price / last year's earnings
- 39.2×
- Today's range
- 27.3528.11
- Past year's range
- 22.9330.35
- Yesterday's close
- $27.54
- Swings vs the market
- 0.3×smaller
- Dividend yield
- 6.27%$1.72 a year